Rep. Brian K. Fitzpatrick

Maddy summaryThe Preserving Seniors’ Access to Physicians Act of 2023 increases the Medicare payment adjustment rate for physicians from 1.25% to 4.62%, directly affecting doctors who treat Medicare patients (primarily seniors). It also reduces the funding for the Medicaid improvement fund from $5,796,117,810 to $3,973,117,810. These changes impact Medicare providers and Medicaid programs, with the Medicare adjustment aimed at supporting physicians adjusting to payment changes. The bill does not specify how the Medicaid funding reduction relates to its stated goal of preserving seniors' access to physicians.

Maddy summaryThe FOREST Act of 2023 prohibits U.S. imports of products made from commodities (palm oil, soybeans, cocoa, cattle, and rubber) produced on land where illegal deforestation occurred after the law's enactment. Importers must file declarations demonstrating they've assessed supply chain risks of illegal deforestation, with stricter requirements for products from countries identified in action plans. The law establishes a process to identify countries without adequate deforestation protections and requires them to develop action plans with specific benchmarks for compliance. It creates a fund using import penalty revenue to provide foreign assistance to help countries eliminate illegal deforestation and includes procurement preferences for federal contracts with suppliers demonstrating deforestation-free supply chains.

Maddy summaryThis bill modifies Medicare Part B late enrollment penalties to better accommodate people with temporary coverage gaps. It increases the penalty rate from 10% to 15% of the monthly premium but limits the penalty period to twice the months without coverage (instead of 12-month increments). It also excludes months with COBRA, retiree, or VA health coverage from penalty calculations and creates a special enrollment period when such coverage ends. These changes directly affect Medicare Part B enrollees who lost employer or retiree coverage, reducing their potential extra fees for late enrollment.

Maddy summaryHR 6465, the PLASMA Act, amends Medicare Part D's discount program to create a specific phase-in for plasma-derived specialty drugs. It directly affects Medicare Part D beneficiaries who use these drugs and reach their annual out-of-pocket spending limit. The bill establishes a new "specified plasma-derived product percent" to calculate discounted prices for these drugs, based on whether beneficiaries have already met their out-of-pocket threshold for other Part D drugs. This changes how manufacturers' negotiated prices are discounted for plasma-derived products under the existing program, without creating new benefits or altering coverage.

Maddy summaryThis bill adds audiology services to Medicare's covered benefits under Section 1861(s)(2)(KK), effective January 1, 2025. It allows qualified audiologists to provide hearing and balance assessments and diagnostic/treatment services without requiring a physician referral or supervision, directly affecting Medicare beneficiaries seeking these services and audiologists practicing under state law. Payment will be 80% of the lower of actual charge or the Medicare fee schedule. The bill does not expand the types of audiology services covered but changes how they are accessed and paid for under Medicare.

Maddy summaryHR 6417 amends the existing "Ending Importation of Russian Oil Act" to ban imports of energy products (classified under Harmonized Tariff Schedule chapter 27) produced at any refinery using crude oil originating in Russia. This directly affects U.S. importers and companies bringing in such refined petroleum products. The key provision prohibits these imports regardless of where the refinery is located, targeting oil that has been "laundered" through foreign processing. The bill updates the existing law by adding this origin-based import ban as a new section.

Maddy summaryThis bill amends Medicare, Medicaid, and private insurance rules to improve coverage for drugs treating rare diseases (defined as conditions affecting 200,000 or fewer people in the U.S.). It requires coverage for rare disease drug uses supported by peer-reviewed medical literature and not listed as contraindicated in FDA labeling or medical reference guides. Private insurers must provide expedited review processes for denials of such drugs. The changes apply 30 days after enactment, affecting insurers and patients seeking coverage for rare disease treatments.

Maddy summaryThe Ejiao Act of 2023 prohibits the import, export, transportation, sale, or purchase of donkeys, donkey hides, and products containing ejiao (a gelatin made from donkey skin) within U.S. borders. It directly affects U.S. businesses and consumers involved in trading these items, aiming to reduce global demand driving the slaughter of millions of donkeys - particularly harming communities in Africa and Latin America that rely on donkeys for farming, transportation, and livelihoods. Key mechanisms include civil penalties of up to $10,000 per violation, criminal penalties for severe breaches (including fines and imprisonment), and mandatory forfeiture of violative goods. The bill is grounded in congressional findings that the donkey skin trade has caused population collapses (e.g., 76% decline in China since 1992) and devastating social impacts on impoverished families.

Maddy summaryThis bill, titled "Freezing HAMAS Act" (though it concerns Iran sanctions, not Hamas), reinstates U.S. sanctions on Iran that were previously waived or suspended under agreements with Iran. It specifically targets sanctions from the 2012 Iran Freedom and Counter-Proliferation Act and the 2012 National Defense Authorization Act, including a September 2023 waiver related to fund transfers. The bill prohibits the U.S. government from releasing funds or assets to Iran or granting further waivers related to these sanctions. It directly affects U.S. government actions regarding Iran financial transactions and enforcement of existing sanctions.

Maddy summaryHR 5819, the COMPLETE Care Act, incentivizes Medicare primary care providers to integrate behavioral health services by increasing payments for specific services (like mental health and substance use disorder support) during 2025-2027. Providers using designated HCPCS codes for integrated care would receive 125-175% of standard payment rates, with the percentage declining annually. The bill also requires these providers to report on integration quality measures and mandates technical assistance for practices adopting integrated models, funded through new appropriations for 2024-2027. It directly affects Medicare-participating primary care practices serving beneficiaries needing mental health or substance use services.